bmi for semaglutide Who Qualifies GLP-1 Injections for Weight Loss? STEP 1 : Semaglutide Treatment

4.7 (3.7, 6.0) kg/m2 (P-value=0.04)

Genetic factors and biomarkers may help contextualize why some patients experience musculoskeletal discomfort while others don't, supporting more informed conversations with healthcare

Studies have shown that anywhere from 15 to 60 percent of the weight people lose on GLP-1's is lean muscle.

FDA approved for effective blood sugar control and appetite suppression.

Understanding Semaglutide: A GLP-1 Receptor Agonist Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist (a medication that mimics a natural hormone regulating blood sugar and appetite)

To help navigate this shifting environment, pharma companies should consider the following imperatives: GLP1s are expanding far beyond diabetes and obesity